Zu Hauptinhalt springen
Gewählte Sprache ist Deutsch Select language
Startseite UR

PD Dr. Birgit Kraus

Dr. kraus

akademische rätin

Birgit1

PD Dr. Birgit Kraus

Gebäude Chemie-Pharmazie, Zi. CH 14.2.83
Telefon: +49 (0)941 943-4494
Fax: +49 (0)941 943-4990
E-Mail: birgit1.kraus@chemie.uni-regensburg.de

vita

Publikationen

Originalpaper

[22] Flemming M., Kraus B., Rascle A., Jürgenliemk G., Fuchs S., Fürst R., Heilmann J.
Revisited anti-inflammatory activity of matricine in vitro: Comparison with chamazulene.
Fitoterapia. 2015, 106:122-8.

[21] Zenger K., Dutta S., Wolff H., Genton M.G., Kraus B.
In vitro structure-toxicity relationship of chalcones in human hepatic stellate cells.
Toxicology. 2015, 336:26-33.

[20] Zenger K., Agnolet S, Schneider B, Kraus B.
Biotransformation of Flavokawains A, B, and C, Chalcones from Kava (Piper methysticum), by Human Liver Microsomes.
J Agric Food Chem. 2015, 63(28):6376-85.

[19] Yancheva D., Cherneva E., Quick M., Mikhova B., Shivachev B., Nikolova R., Djordjevic A., Untergehrer M., Jürgenliemk G., Kraus B., Smelcerovic A.
Synthesis, Crystal Structure and Biological Activity Screening of Novel N-(α-Bromoacyl)-α-amino Esters Containing Valyl Moiety.
Acta Chim. Slov. 2015, 62(3):689-99.

[18] Rengstl D., Kraus B., Van Vorst M., Elliott G.D., Kunz W.
Effect of choline carboxylate ionic liquids on biological membranes.
Colloids and surfaces B: Biointerfaces, 2014, 123:575-81.

[17] Kremb S., Helfer M., Kraus B., Wolff H., Wild C., Schneider M., Voolstra C., Brack-Werner R.
Aqueous extracts of the marine brown alga Lobophora variegata inhibit HIV-1 infection at the level of virus entry into cells.
PLoS One. 2014, 9(8):e103895.

[16] Klein R., Maurer E., Kraus B., Brunner G., Estrine B., Touraud D., Heilmann J., Kellermeier M., Kunz W.
Biodegradability and cytotoxicity on human cell lines of choline soaps: effects of chain length and cation.
RSC Adv. 2013, 3(45):23347-23354.

[15] Zenger K., Chen X., Decker M., Kraus B.
In-vitro stability and metabolism of a tacrine-silybinin codrug.
J Pharm Pharmacol. 2013, 65(12):1765-1772.

[14] Bachl J., Huber T., Kühbeck D., Schön E.-M., Brunner G., Kraus B., Heilmann J., Codelli J. A., Bertozzi C. R., Cativiela C., Díaz Díaz D.
Hybrid bioactive hydrogels containing single-walled carbon nanotubes covalently integrated via strain-promoted azide-alkyne cycloaddition.
Nanosci. and Nanotech. Asia. 2012, 2:200-209.

[13] Chen X., Zenger K., Lupp A., Kling B., Heilmann J., Fleck C., Kraus B., Decker M.
A Tacrine-Silibinin Co-Drug Shows Neuro- and Hepatoprotective Effects In Vitro and Pro-Cognitive and Hepatoprotective Effects In Vivo.
J. Med. Chem. 2012, 55(11):5231-5242.

[12] Romanski S., Kraus B., Schlundt W., Guttentag M., Adler A., Neudörfl J.M., Alberto R., Amslinger S., Schmalz H.G.
Acyloxybutadiene Tricarbonyl Iron Complexes as Enzyme-Triggered CO-Releasing Molecules (ET-CORMs): A Structure-Activity-Relationship Study.
Dalton Trans. 2012, 41(45):13862-13875.

[11] Freischmidt A., Jürgenliemk G., Kraus B., Okpanyi S.N., Müller J., Kelber O., Weiser D., Heilmann J.
Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardized Willow bark extract.
Phytomedicine. 2012, 19(3-4):245-252.

[10] Motyl M., Kraus B., Heilmann J.
Pitfalls in cell culture work with xanthohumol.
Pharmazie. 2012, 67:91-94.

[9] Wolff H., Motyl M., Hellerbrand C., Heilmann J., Kraus B.
Xanthohumol uptake and intracellular kinetics in hepatocytes, hepatic stellate cells and intestinal cells.
J. Agric. Food Chem. 2011, 59(24):12893–12901.

[8] Romanski S., Kraus B., Schatzschneider U, Neudörfl J.M., Amslinger S., Schmalz H.G.
Acyloxybutadiene–Iron Tricarbonyl Complexes as Enzyme-Triggered CO-Releasing Molecules.
Angew. Chem. Int. Ed. Engl. 2011, 50(10):2392-6.

[7] Kraus B., Wolff H., Elstner E.F., Heilmann J.
Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381(6):541-53.

[6] Dorn C, Kraus B, Motyl M, Weiss TS, Gehrig M, Schölmerich J, Heilmann J, Hellerbrand C.
Xanthohumol, a chalcone from hops, inhibits hepatic inflammation and fibrosis.
Mol. Nutr. Food Res. 2010, 54 Suppl 2:S205-13.

[5] Wolff H., Zenger K., Kraus B.
Progress in live-cell imaging and screening applications using Definite Focus.
Biotechniques. 2009, 47(5):976–978.

[4] Fang L., Kraus B., Lehmann J., Heilmann J., Zhang Y., Decker M.
Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates.
Bioorg. Med. Chem. Lett. 2008, 18(9):2905-9.

[3] Decker M., Kraus B., Heilmann J.
Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.
Bioorg. Med. Chem. 2008, 16(8):4252-61.

[2] Kraus B., Wolff H.
High Content Analysis with AxioVision ASSAYbuilder™: Applications in Pharmaceutical Biology.
Biotechniques. 2008, 44(6):820-3.

[1] Kraus B., Wolff H., Heilmann J., Elstner E.F.
Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells.
Life Sci. 2007, 81(11):884-94.


Buchkapitel

Kraus B., Ziegler M. and Wolff H.
Linear fluorescence unmixing in cell biological research.
In: Méndez-Vilas A., Díaz J. (Eds.) Modern Research and Educational Topics in Microscopy, Volume 2. Bandajoz, Spain: Formatex, 2007, 863-872.

  1. STARTSEITE UR

Birgit Kraus

Dr.
Birgit Kraus
Birgit1

Gebäude CH, Zi. 14.2.83
Telefon 0941-943-4494
Telefax 0941-943-4990
e-Mail